Document is current

Article History

Received: 31 March 2023

Accepted: 27 April 2023

First Online: 3 May 2023

Declarations

:

: This study is conducted in keeping with the principles for research ethics according to the Helsinki Declaration, including written informed consent by all participants and protection of the integrity and dignity of individuals. The study was approved by the Regional Ethical Review Committee in Sweden. The reference number is 2021–05962-01.

: Not applicable.

: HK reports consulting fees from Bayer AB and Campus Pharma for giving lectures or running educational events. KEI reports payment or honoraria for presentation from Bayer AB and for travel support for presentation at conference from RemovAid AS.KGD reports consulting fees from Bayer, MSD, Organon, Gedeon Richter, Mithra, Exeltis, MedinCell, Cirqle, Natural Cycles, Exelgyn, Campus Pharma, HRA-Pharma; payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Bayer, MSD, Organon, Gedeon Richter, Mithra, Exeltis, Exelgyn, Campus Pharma; participation on a Data Safety Monitoring Board or Advisory Board: Gedeon Richter, Bayer; leadership or fiduciary role in other board, society, committee or advocacy group, paid or unpaid: FIGO, WHO HRP/SRH, ESC, FIAPAC, FSRH/RCOG UK, Population Council.The other co-authors have stated that they have no conflicts of interest in connection with this manuscript.